A947
A947 is a potent and selective SMARCA2 proteolysis-targeting chimera molecule (PROTAC) . A947 also is a potent and moderately selective SMARCA2 degrader. A947 has binding affinity to the SMARCA2 bromodomain with a Kd value of 93 nM. A947 can be used for the research of cancer[1].
Product Specifications
CAS Number
2378056-80-3
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain; PROTACs
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/a947.html
Solubility
10 mM in DMSO
Smiles
NC1=C(C=C(C(C=CC=C2)=C2O)N=N1)N3C[C@H](CC4)N(C5=CC=NC(O[C@H](C6)C[C@@H]6OC(CC7)CCN7CC8CCN(C9=NOC([C@@H](C(C)C)C(N(C[C@@H]%10O)[C@@H](C%10)C(N[C@H](C%11=CC=C(C(SC=N%12)=C%12C)C=C%11)C)=O)=O)=C9)CC8)=C5)[C@H]4C3
Molecular Formula
C61H76N12O7S
Molecular Weight
1121.40
References & Citations
[1] Jennifer Cantley, et al. Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers. Nat Commun. 2022 Nov 10;13 (1) :6814.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6306173-01 0.1 mL
HERC3, NT (HERC3, KIAA0032, Probable E3 ubiquitin-protein ligase HERC3, HECT domain and RCC1-like domain-containing protein 3) (MaxLight 750)
Sign In for Pricing
View Details MBS6306173-02 5x 0.1 mL
HERC3, NT (HERC3, KIAA0032, Probable E3 ubiquitin-protein ligase HERC3, HECT domain and RCC1-like domain-containing protein 3) (MaxLight 750)
Sign In for Pricing
View Details TL704550V 500 µL Each
F13b Rat shRNA Lentiviral Particle (Locus ID 289055)
Sign In for Pricing
View Details 
